See more : B. Riley Financial, Inc. – 6.50 (RILYN) Income Statement Analysis – Financial Results
Complete financial analysis of JW Holdings Corporation (096760.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of JW Holdings Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Hung Sheng Construction Ltd. (2534.TW) Income Statement Analysis – Financial Results
- Fukuda Corporation (1899.T) Income Statement Analysis – Financial Results
- QTC Energy Public Company Limited (QTC.BK) Income Statement Analysis – Financial Results
- AKIBA Holdings Co.,Ltd. (6840.T) Income Statement Analysis – Financial Results
- Kape Technologies PLC (KAPE.L) Income Statement Analysis – Financial Results
JW Holdings Corporation (096760.KS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jw-holdings.co.kr
About JW Holdings Corporation
JW Holdings Corporation, together with its subsidiaries, manufactures and sells medicines and medical devices in South Korea and internationally. It offers ETC products, consumer healthcare OTC products, and IV solutions machinery systems. The company also exports its products. JW Holdings Corporation was founded in 1945 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 928.07B | 864.54B | 788.94B | 781.51B | 726.42B | 725.37B | 683.72B | 680.48B | 622.62B | 573.92B | 530.26B | 511.95B | 516.01B | 554.24B | 556.68B | 529.24B | 237.69B |
| Cost of Revenue | 481.91B | 464.58B | 444.76B | 474.24B | 440.29B | 415.46B | 386.41B | 403.21B | 366.31B | 338.25B | 309.01B | 312.59B | 306.06B | 314.02B | 296.87B | 277.46B | 130.77B |
| Gross Profit | 446.16B | 399.96B | 344.18B | 307.28B | 286.13B | 309.91B | 297.31B | 277.27B | 256.30B | 235.67B | 221.25B | 199.36B | 209.96B | 240.22B | 259.81B | 251.78B | 106.92B |
| Gross Profit Ratio | 48.07% | 46.26% | 43.63% | 39.32% | 39.39% | 42.72% | 43.48% | 40.75% | 41.17% | 41.06% | 41.73% | 38.94% | 40.69% | 43.34% | 46.67% | 47.57% | 44.98% |
| Research & Development | 33.73B | 33.15B | 17.76B | 23.13B | 22.40B | 17.90B | 24.02B | 20.46B | 18.59B | 20.06B | 16.30B | 15.89B | 14.97B | 16.52B | 9.91B | 7.98B | 3.18B |
| General & Administrative | 91.70B | 81.28B | 65.69B | 63.90B | 74.19B | 68.49B | 62.24B | 59.74B | 54.74B | 38.74B | 43.81B | 36.67B | 43.39B | 41.01B | 35.18B | 32.61B | 15.84B |
| Selling & Marketing | 58.92B | 55.75B | 63.89B | 53.85B | 54.60B | 56.40B | 49.32B | 52.88B | 47.63B | 56.40B | 52.56B | 40.01B | 36.13B | 40.74B | 57.23B | 59.75B | 26.84B |
| SG&A | 150.62B | 137.03B | 129.58B | 117.75B | 128.79B | 124.89B | 111.56B | 112.62B | 102.37B | 95.14B | 96.37B | 76.68B | 79.52B | 81.75B | 92.41B | 92.36B | 42.69B |
| Other Expenses | 116.91B | 116.44B | 128.11B | 129.07B | 132.21B | -254.28M | 436.85M | -4.46B | -936.84M | -2.83B | 1.75B | 1.99B | 133.17M | -9.10B | -10.76B | -10.85B | -7.33B |
| Operating Expenses | 301.26B | 286.62B | 275.45B | 269.95B | 283.40B | 276.61B | 256.07B | 238.28B | 223.05B | 212.18B | 200.83B | 195.69B | 197.60B | 204.24B | 208.57B | 206.37B | 95.21B |
| Cost & Expenses | 784.41B | 751.19B | 720.21B | 744.19B | 723.69B | 692.07B | 642.49B | 641.49B | 589.37B | 550.43B | 509.84B | 508.27B | 503.65B | 518.26B | 505.44B | 483.83B | 225.98B |
| Interest Income | 6.69B | 445.89M | 2.36B | 1.23B | 702.22M | 557.47M | 419.36M | 277.74M | 708.58M | 417.50M | 832.19M | 2.00B | 365.66M | 466.27M | 2.05B | 2.94B | 999.96M |
| Interest Expense | 32.53B | 25.29B | 21.46B | 25.90B | 31.80B | 32.51B | 34.48B | 32.01B | 34.30B | 37.80B | 44.32B | 54.35B | 46.18B | 42.13B | 27.25B | 20.82B | 8.40B |
| Depreciation & Amortization | 44.22B | 40.13B | 38.38B | 42.91B | 42.17B | 34.96B | 32.03B | 22.23B | 21.72B | 20.27B | 25.40B | 28.97B | 27.11B | 21.37B | 29.97B | 32.15B | 12.68B |
| EBITDA | 128.53B | 150.83B | 100.52B | 80.24B | 47.59B | 67.90B | 73.74B | 66.27B | 56.26B | 38.51B | 91.20B | 36.75B | 30.10B | 59.95B | 75.02B | 67.72B | 17.18B |
| EBITDA Ratio | 13.85% | 16.85% | 13.62% | 17.25% | 6.23% | 9.39% | 18.16% | 9.30% | 9.19% | 8.55% | 17.32% | 7.64% | 7.44% | 10.99% | 13.27% | 11.38% | 7.31% |
| Operating Income | 144.90B | 103.26B | 68.73B | 91.87B | 2.74B | 33.31B | 41.42B | 43.35B | 33.46B | 23.50B | 20.42B | 3.67B | 6.12B | 41.21B | 51.24B | 45.40B | 11.71B |
| Operating Income Ratio | 15.61% | 11.94% | 8.71% | 11.76% | 0.38% | 4.59% | 6.06% | 6.37% | 5.37% | 4.09% | 3.85% | 0.72% | 1.19% | 7.43% | 9.20% | 8.58% | 4.93% |
| Total Other Income/Expenses | -91.51B | -32.26B | -36.24B | -13.73B | -28.77B | -32.89B | 16.84B | -31.97B | -33.22B | -36.60B | 1.06B | -50.24B | -49.31B | -42.38B | -33.44B | -30.66B | -15.61B |
| Income Before Tax | 53.39B | 70.99B | 32.49B | 23.60B | -26.08B | 427.19M | 56.92B | 11.38B | 239.58M | -7.84B | 21.48B | -46.56B | -43.19B | -3.55B | 17.80B | 14.75B | -3.90B |
| Income Before Tax Ratio | 5.75% | 8.21% | 4.12% | 3.02% | -3.59% | 0.06% | 8.32% | 1.67% | 0.04% | -1.37% | 4.05% | -9.10% | -8.37% | -0.64% | 3.20% | 2.79% | -1.64% |
| Income Tax Expense | 22.36B | 24.51B | 28.05B | 20.21B | 5.55B | 7.25B | 48.44M | 25.76B | -96.74M | -2.75B | 5.31B | -5.09B | 1.54B | 6.14B | 8.39B | 16.17B | 6.05B |
| Net Income | 19.03B | 46.48B | 4.43B | 3.39B | -31.64B | 23.17B | 54.02B | -8.66B | 181.41M | -8.99B | 17.82B | -22.03B | -32.11B | -11.56B | 1.04B | -5.17B | -7.23B |
| Net Income Ratio | 2.05% | 5.38% | 0.56% | 0.43% | -4.36% | 3.19% | 7.90% | -1.27% | 0.03% | -1.57% | 3.36% | -4.30% | -6.22% | -2.09% | 0.19% | -0.98% | -3.04% |
| EPS | 271.00 | 643.24 | 62.77 | 47.18 | -428.11 | 326.07 | 74.04 | -126.39 | 2.56 | -134.14 | 279.08 | -345.09 | -493.37 | -172.74 | 16.85 | -81.73 | -175.26 |
| EPS Diluted | 270.66 | 643.24 | 62.77 | 47.18 | -428.11 | 326.07 | 74.04 | -126.39 | 2.56 | -134.14 | 279.08 | -345.09 | -493.37 | -172.74 | 16.85 | -81.59 | -175.26 |
| Weighted Avg Shares Out | 70.21M | 72.26M | 70.65M | 71.75M | 73.90M | 71.05M | 70.75M | 68.55M | 70.81M | 67.01M | 63.84M | 63.85M | 65.09M | 66.94M | 61.76M | 63.20M | 41.27M |
| Weighted Avg Shares Out (Dil) | 70.30M | 72.26M | 70.65M | 71.75M | 73.90M | 71.05M | 70.75M | 68.55M | 70.81M | 67.01M | 63.84M | 63.85M | 65.09M | 66.94M | 61.76M | 63.31M | 41.27M |
No news found for: 096760.KS
Source: https://incomestatements.info
Category: Stock Reports